ArticleCureus2025
Comparison of Serum Matrix Metalloproteinase-9 Levels in Diabetic and Non-diabetic Chronic Wounds.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multidimensional Regulatory Mechanisms and Targeted Therapeutic Strategies for Inhibited Keratinocyte Proliferation in Diabetic Wounds.Drug design, development and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWound healing relies on a balance between extracellular matrix remodelling by matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). Among all the MMPs, elevated MMP-9 levels are implicated in chronic wounds including diabetic ulcers, making it a potential biomarker to predict wound healing. This in turn can help determine the need for aggressive wound care management. However, most studies used invasive sampling methods like wound fluid or tissue biopsy limiting clinical implementation. Hence, this study assessed the correlation between serum levels of MMP-9 in diabetic and non-diabetic chronic wounds to explore if non-invasive methods could be used to predict healing in diabetic chronic wounds.
objectiveThis study aimed to compare serum MMP-9 levels in diabetic vs. non-diabetic chronic wounds, assess correlations with glycemic control (glycated hemoglobin (HbA1c)), and determine the potential of serum MMP-9 as a predictor of healing in diabetic chronic wounds.
methodsThis was a cross-sectional study involving 40 patients (20 diabetics, 20 non-diabetics) with chronic wounds. Serum MMP-9 levels were measured from blood samples (avoiding invasive methods) using an enzyme-linked immunosorbent assay (ELISA). HbA1c levels were obtained for patients with diabetes mellitus. Statistical analysis compared means (t-test) and correlations (Pearson's).
resultsPatients with diabetes mellitus had significantly higher serum MMP-9 (mean 21.22 ng/ml) in comparison to non-diabetics (17.35 ng/ml; p=0.0023). When compared to only 5% (one out of 20) of non-diabetics, about 75% (15 out of 20) of diabetics had MMP-9 greater than 20 ng/ml. However, no correlation was found between MMP-9 and HbA1c levels (p>0.05) among diabetic patients.
conclusionsSerum MMP-9 is elevated in diabetic chronic wounds, supporting its role as a non-invasive biomarker. Several studies have established wound fluid/tissue MMP-9 as a predictor of healing in diabetic ulcers, and this study suggests that serum MMP-9 levels could be used as a non-invasive biomarker in place of cumbersome methods. However, the lack of association of MMP-9 with HbA1c suggests glycemic control alone may not regulate MMP-9. Targeting MMP-9 inhibition (e.g., via microRNAs) could be a therapeutic strategy, warranting further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.